Listed pahrmas weakened in profitability

Published: 2018-08-20 16:37:38

Updated: 2018-08-20 16:37:38

It was criticized listed pharmaceutical companies have been weakened in profitability.

Yakup Shinmoon(www.yakup.com) analyzed KOSPI and KOSDAQ listed pharmaceutical companies’ 2018 2^nd quarter business performance, and the analysis result showed that they made sales 10% more than what they made last year. (holding and biopharmaceutical companies excluded from the analysis)

However, their oper...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.